Deffai careers

In the near future, drug discovery will no longer be the bottleneck in life sciences: Eli Lilly's $2B+ partnership with Insilico Medicine, Anthropic's $400M+ acquisition of Coefficient Bio, and OpenAI's partnership with Novo Nordisk. Capital and resources are flowing into drug discovery, but this doesn't address the downstream bottleneck — if there is an abundance of molecules discovered, how eligible are they for regulatory approval and commercialization?

Deffai is reimagining how drugs are approved by the FDA with cutting-edge AI purpose-built for medical devices, drugs, and therapeutics companies. We're building the world's largest FDA regulatory AI by combining FDA regulatory expertise and data from diverse sources.

Our team is made of passionate domain experts and experienced entrepreneurs across life sciences and software products. We're a mission-driven and energetic team excited to build the future of FDA regulatory approval.

We're growing quickly and looking for ambitious builders who want to tackle hard technical problems, move fast, and have real impact on how medicines are made and approved.